Stephen Reese
Clifford Chance LLPData protection and cyber matters, financing for acquisitions and high-profile appeals of decisions made by the Competition and Markets Authority stand out as areas of activity for the team at Clifford Chance LLP. Stephen Reese and Gareth Camp jointly oversee the practice. Reese is equipped to advise clients on the UK and EU regulatory aspects of pharmaceuticals biologics and medical devices and their interplay with IP strategy, while Camp is frequently tasked with leading life sciences and healthcare transactions. Corporate compliance and investigations partner Luke Tolaini‘s practice extends to crisis management and ethical and compliance failings. Alex Walker focuses his practice on advising clients on the protection, exploitation, use and enforcement of their IP rights.
Legal 500 Editorial commentary
Key clients
- Pfizer
- Cinven
- EQT Infrastructure
- GE HealthCare
- Xellia Pharmaceuticals ApS and
- Alpharma LLC ("Alpharma")
- Gilead Sciences
- Her Majesty's Government (HMG), Department for Business, Energy and Industrial Strategy (BEIS)
Work highlights
- Acting for Cinven in relation to a high-profile appeal before the Competition Appeal Tribunal ("CAT") against CMA Decisions for the alleged antitrust infringements of a former portfolio company active in generic pharmaceuticals, now named Advanz.
- Advised a Medicinal Cannabis developer and manufacturer in connection with an IP licensing contractual dispute concerning their global development and commercialisation of Cannabis medicinal products.
- Assisting a global pharmaceutical and healthcare corporation with various data protection and cyber matters.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
The lawyer(s) leading their teams.
Stephen Reese, Gareth Camp